Document is current
Any future updates will be listed below
-
Authors
Guida, Eugenia
Colopi, Ambra
Cesarini, Valeriana
Pieraccioli, Marco
Mignini, Luca
Di Cesare, Silvia
Martini, Maurizio
Gessi, Marco
Salvati, Maurizio
Nicolis, Silvia Kirsten
Caffo, Maria
Jannini, Emmanuele Angelo
Dolci, Susanna
-
Funding
Funding for this research was provided by:
Ministero dell'Università e della Ricerca (Prin 2022X4FWZ5)
Ministero dell'Università e della Ricerca (Prin 2022AWB8T4)
Ministero dell'Università e della Ricerca (Prin 2022X4FWZ5)
- License Information
-
More Information
Article History
Received: 2 September 2025
Accepted: 8 April 2026
First Online: 20 April 2026
Competing interests
: E.A.J. is or has been a consultant and/or paid speaker for Bayer, FQM, Ibsa, Kanna, Menarini, Merck, Otsuka, Pfizer, Recordati, Shionogi, and Viatris. The other authors declare no competing interests.
